Skip to content

A prospective protocol for serum metabolites and omics studies in patients with depression

A prospective trial of serum metabolites and omics studies in patients with depression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069314
Enrollment
Unknown
Registered
2023-03-13
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

Case series:NA

Sponsors

Wuxi Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The sample is derived from the remaining sample of clinical testing, and the remaining sample size meets: >= 1 mL of human serum sample; 2. Meet the storage requirements, that is, the samples must be stored at room temperature after collection and centrifuged within 12 hours after collection. It is then stored protected from light at -60 °C until analysis; 3. Patients are aged 18-60 years old, gender is not limited; 4. Patients 3 days ± sample collection meet one of the following clinical conditions: (1) First episode, not receiving any medication, Hamilton (HAMD) scale assessment: 24 Hamilton Depression Scale overall score > 20; (2) Meet the diagnostic criteria for depression in the Primary Diagnosis and Treatment Guidelines for Depression (2021), Hamilton (HAMD) scale assessment: 24 Hamilton Depression Scale overall scores > 20 points; (3) Patients diagnosed with depression according to the Primary Care Guidelines for Depression (2021) improved after medical treatment and were rated on the Hamilton (HAMD) scale: The total score of the 24 Hamilton Depression Scales was < 8.

Exclusion criteria

Exclusion criteria: 1. The sample showed coagulation or hemolysis; 2. Incorrect collection or storage of samples; 3. The subject has other psychiatric diseases at the same time; 4. Those who are dependent on drugs or alcohol or have a history of abuse; 5. Patients with neurological lesions, brain trauma, cardiovascular and cerebrovascular diseases, severe liver and kidney dysfunction, diabetes and other major physical diseases; 6. Pregnant or lactating women; 7. Those who have surgery or other major medical history within 6 months; 8. Are receiving hormonal therapy; 9. Subjects who the investigator believes have other factors that are not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Metabolomics;

Countries

China

Contacts

Public ContactWang Jun

Wuxi Mental Health Center

woodfish2@126.com+86 133 5811 9628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026